Comparing Lung Cancer Screening Criteria for Racial Disparity in Eligibility

JAMA Oncology

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JANUARY 13, 2022

Media advisory: The full study and commentary are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.6720?guestAccessKey=46113213-0bcc-4a03-a1c3-c4ea5e7383a2&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=011322

 

What The Study Did: The findings of this study suggest that the 2021 U.S. Preventive Services Task Force guideline changes improve on earlier, fixed screening criteria for lung cancer, broadening eligibility and reducing the racial disparity in access to screening.

Authors: Chan Yeu Pu, M.D., M.S., of the Wayne State University School of Medicine in Detroit, is the corresponding author.

 

(doi:10.1001/jamaoncol.2021.6720)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.